| |
Survivors(n = 39)
|
Deaths (n = 7)
|
p value
|
|---|
|
Age
|
62 (22, 85)
|
68 (55, 78)
|
0.668
|
|
Gender
| | | |
|
Male
|
30 (76.9)
|
6 (85.7)
|
1.000
|
|
Female
|
9 (23.1)
|
1 (14.3)
| |
|
Underlying disease
| | | |
|
Viral hepatitis
|
13 (33.3)
|
5 (71.4)
|
0.093
|
|
Liver cirrhosis
|
4 (10.2)
|
4 (57.1)*
|
0.012
|
|
Chronic liver dysfunction
|
13 (33.3)
|
6 (85.7)*
|
0.015
|
|
Diabetes mellitus
|
16 (41.0)
|
2 (28.6)
|
0.688
|
|
Chronic renal failure
|
5 (12.8)
|
4 (57.1)*
|
0.020
|
|
Immunocompromised(DM, liver dysfunction, CRF, malignancy)
|
27 (69.2)
|
7 (100)
|
0.165
|
|
Pathogens
| | | |
|
Gram positive pathogen
|
10 (25.6)
|
1 (14.3)
|
0.667
|
|
Gram negative pathogen
|
29 (74.4)
|
6 (85.7)
| |
|
Involved region
| | | |
|
Upper extremity
|
11 (28.2)
|
4 (57.1)
|
0.193
|
|
Lower extremity
|
28 (71.8)
|
3 (42.9)
| |
|
Shock at ER
|
19 (48.7)
|
6 (85.7)
|
0.106
|
- Data are presented as median (min, max) or frequency (%)
- Chronic liver dysfunction: liver cirrhosis, viral hepatitis (HBV, or HCV)
- *: The difference is significant (p < 0.05)
